Literature DB >> 12580897

Vascular endothelial growth factor-B and retinal vascular development in the mouse.

Melissa Reichelt1, Shunning Shi, Mark Hayes, Graham Kay, Jennifer Batch, Glen A Gole, Jay Browning.   

Abstract

PURPOSE: Vascular endothelial growth factor-A (VEGF-A) is crucial to retinal vascular growth, both normal and pathological. VEGF-B, recently characterized, is reported to be expressed in retinal tissues, but the importance of VEGF-B to retinal vascular development remained unknown. The aim of this study was to analyse retinal vascular growth in the Vegfb-/- knockout mouse.
METHODS: Retinal vascular growth was measured in Vegfb-/- knockout mice raised under normal conditions, and Vegfb-/- knockout mice with an oxygen-induced proliferative retinopathy. Wild type Vegfb+/+ mice served as controls. Vessels were perfused with ink and retinal flatmounts secondarily labelled with FITC-lectin (BS-1, Griffonia simplicifolia). Area and diameter of retinal growth and retinal vascular growth were recorded over days 0-20, and capillary density and mean diameter recorded from day 17 pups.
RESULTS: A variety of techniques confirmed that Vegfb+/+ mice expressed VEGF-B and that VEGF-B expression was absent in Vegfb-/- mice. Vegfb-/- mice raised in room air showed no significant differences from Vegfb+/+ controls. No differences were found in oxygen-induced retinopathy between Vegfb-/- and Vegfb+/+ pups in either the extent of the initial oxygen-induced ablation, or in the regrowth of retinal vessels or vitreal (neovascular) sprouts; vitreal sprouts are important markers of the abnormal proliferative response, and are maximally expressed on day 17 in this model of oxygen-induced retinopathy.
CONCLUSIONS: These results indicate that a lack of VEGF-B does not significantly affect development of the retinal vasculature under normal conditions, nor does it appear to affect the proliferative retinal responses seen in oxygen-induced retinopathy.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12580897     DOI: 10.1046/j.1442-9071.2003.00602.x

Source DB:  PubMed          Journal:  Clin Exp Ophthalmol        ISSN: 1442-6404            Impact factor:   4.207


  19 in total

1.  VEGF-B is dispensable for blood vessel growth but critical for their survival, and VEGF-B targeting inhibits pathological angiogenesis.

Authors:  Fan Zhang; Zhongshu Tang; Xu Hou; Johan Lennartsson; Yang Li; Alexander W Koch; Pierre Scotney; Chunsik Lee; Pachiappan Arjunan; Lijin Dong; Anil Kumar; Tuomas T Rissanen; Bin Wang; Nobuo Nagai; Pierre Fons; Robert Fariss; Yongqing Zhang; Eric Wawrousek; Ginger Tansey; James Raber; Guo-Hua Fong; Hao Ding; David A Greenberg; Kevin G Becker; Jean-Marc Herbert; Andrew Nash; Seppo Yla-Herttuala; Yihai Cao; Ryan J Watts; Xuri Li
Journal:  Proc Natl Acad Sci U S A       Date:  2009-04-06       Impact factor: 11.205

2.  VEGF and Notch in tip and stalk cell selection.

Authors:  Raquel Blanco; Holger Gerhardt
Journal:  Cold Spring Harb Perspect Med       Date:  2013-01-01       Impact factor: 6.915

3.  VEGF-A and VEGF-B mRNA expression in gastro-oesophageal cancers.

Authors:  Cristina Angelescu; Florin Burada; Mihai Ioana; Radu Angelescu; Emil Moraru; Anca Riza; Sanda Marchian; Francisc Mixich; Mihai Cruce; Adrian Săftoiu
Journal:  Clin Transl Oncol       Date:  2012-08-08       Impact factor: 3.405

Review 4.  The yin and yang of VEGF and PEDF: multifaceted neurotrophic factors and their potential in the treatment of Parkinson's Disease.

Authors:  Torsten Falk; Robert T Gonzalez; Scott J Sherman
Journal:  Int J Mol Sci       Date:  2010-08-05       Impact factor: 5.923

5.  Both Kdr and Flt1 play a vital role in hypoxia-induced Src-PLD1-PKCγ-cPLA(2) activation and retinal neovascularization.

Authors:  Nikhlesh K Singh; Dale E Hansen; Venkatesh Kundumani-Sridharan; Gadiparthi N Rao
Journal:  Blood       Date:  2013-01-14       Impact factor: 22.113

6.  Reevaluation of the role of VEGF-B suggests a restricted role in the revascularization of the ischemic myocardium.

Authors:  Xuri Li; Marc Tjwa; Inge Van Hove; Berndt Enholm; Elke Neven; Karri Paavonen; Michael Jeltsch; Toni Diez Juan; Richard E Sievers; Emmanuel Chorianopoulos; Hiromichi Wada; Maarten Vanwildemeersch; Agnes Noel; Jean-Michel Foidart; Matthew L Springer; Georges von Degenfeld; Mieke Dewerchin; Helen M Blau; Kari Alitalo; Ulf Eriksson; Peter Carmeliet; Lieve Moons
Journal:  Arterioscler Thromb Vasc Biol       Date:  2008-05-29       Impact factor: 8.311

Review 7.  VEGF-B: a survival, or an angiogenic factor?

Authors:  Xuri Li; Chunsik Lee; Zhongshu Tang; Fan Zhang; Pachiappan Arjunan; Yang Li; Xu Hou; Anil Kumar; Lijin Dong
Journal:  Cell Adh Migr       Date:  2009-10-03       Impact factor: 3.405

8.  Effects of vascular endothelial growth factor B on proliferation and migration in EA.Hy926 cells.

Authors:  Guang-Hong Zhang; Rui Qin; Shui-Hua Zhang; He Zhu
Journal:  Mol Biol Rep       Date:  2013-12-30       Impact factor: 2.316

9.  VEGF-B inhibits apoptosis via VEGFR-1-mediated suppression of the expression of BH3-only protein genes in mice and rats.

Authors:  Yang Li; Fan Zhang; Nobuo Nagai; Zhongshu Tang; Shuihua Zhang; Pierre Scotney; Johan Lennartsson; Chaoyong Zhu; Yi Qu; Changge Fang; Jianyuan Hua; Osamu Matsuo; Guo-Hua Fong; Hao Ding; Yihai Cao; Kevin G Becker; Andrew Nash; Carl-Henrik Heldin; Xuri Li
Journal:  J Clin Invest       Date:  2008-03       Impact factor: 14.808

10.  Insulin-like growth factor binding protein-3 in preterm infants with retinopathy of prematurity.

Authors:  Manizheh Mostafa Gharehbaghi; Ali Peirovifar; Karim Sadeghi; Haleh Mostafidi
Journal:  Indian J Ophthalmol       Date:  2012 Nov-Dec       Impact factor: 1.848

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.